Pfizer Schedules Animal Unit IPO as Profit Beats Estimates

Pfizer Schedules Animal Unit IPO as Profit Beats Estimates

JB Reed/Bloomberg

Pfizer’s sales have eroded since its top-seller Lipitor, which generated $9.58 billion last year, lost market exclusivity in November.